HOME >> MEDICINE >> NEWS
Childhood depression may encourage ecstasy use

Children with symptoms of anxiety and depression may have an increased tendency to use ecstasy in adolescence or young adulthood, finds a study published online by the BMJ today.

The use of ecstasy is associated with emotional health problems, such as depression, psychotic symptoms, and anxiety disorders. But it's not clear whether emotional problems are a consequence of using ecstasy or emotional problems lead to ecstasy use.

Researchers in the Netherlands investigated whether use of ecstasy is preceded by symptoms of behavioural and emotional problems in childhood and early adolescence.

They assessed ecstasy use in 1580 individuals from childhood into adulthood. The first assessment took place in 1983, before ecstasy appeared as a recreational drug in the Netherlands. Use of the drug was then assessed 14 years later, providing a unique opportunity to investigate if a pathway from behavioural and emotional problems leading to ecstasy use exists.

Individuals with signs of anxiety and depression in 1983 showed an increased risk of starting to use ecstasy.

Ecstasy's effects are supposed to include enhanced feelings of bonding with other people, euphoria, or relaxation, say the authors. Individuals with signs of anxiety or depression may be particularly susceptible to these positive effects and may therefore use ecstasy to relieve their symptoms.

However, long term exposure to ecstasy may result in increased depressive symptoms. Individuals with signs of anxiety or depression in childhood are at risk of using ecstasy and may develop depressive symptoms. This may explain part of the link that has been found between ecstasy use and later depression in other studies, add the authors.

Other factors not tested in this study may account for the increased tendency to use ecstasy in some individuals. They include the social environment, novelty seeking, or substance use of parents.

"Focusing on these vulnerable in
'"/>

Contact: Emma Dickinson
edickinson@bmj.com
44-207-383-6529
BMJ-British Medical Journal
23-Feb-2006


Page: 1 2

Related medicine news :

1. Childhood obesity indicates greater risk of school absenteeism, Penn study reveals
2. Childhood sun exposure may lower risk of MS
3. Childhood obesity intervention shows promising results
4. Childhood immunization against pneumonia cuts hospital admissions by almost 40 percent
5. Childhood abuse can impact victims adult relationships
6. Childhood lead exposure linked to increased injuries as teens
7. Childhood obesity briefing on Sept. 13
8. Childhood sleep apnea linked to brain damage, lower IQ
9. Childhood obesity caused by toxic environment of Western diets, study says
10. Childhood arthritis raises risk of broken bones
11. Childhood asthma affecting more than just breathing

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/19/2017)... ... 19, 2017 , ... The Semper Fi Fund, one of the nation’s highest-rated ... series of videos and a compelling documentary that provide unique insights and powerful advice ... part of its ongoing mission. , Each of the videos focuses on a specific ...
(Date:9/19/2017)... , ... September 19, 2017 , ... ... searching for solutions to their neck and back pain with a reputable physician ... Allegion Spine Institute , formerly known as Nevada Spine Clinic was founded ...
(Date:9/19/2017)... Ontario (PRWEB) , ... September 19, 2017 , ... Public ... regulation of pollutants have fallen on deaf ears, leaving the water industry itself to ... company that stays ahead of the curve in the field of natural alkaline ...
(Date:9/19/2017)... ... September 19, 2017 , ... The ISO 9001 standard sets out the ... become more efficient and improve customer satisfaction. ISO 9001:2015 was released in 2015 and ... a deadline of September 2018. , As described in this white ...
(Date:9/19/2017)... , ... September 19, 2017 ... ... and cognitive health supplement developed by a neurosurgeon, has received a big ... , Daily Brain Booster is currently available on the Wal-Mart Stores-owned ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... INDIANAPOLIS , Sept. 9, 2017  Eli Lilly ... key primary and secondary endpoint data for lasmiditan, an ... migraine, which demonstrated statistically significant improvements compared to placebo ... be highlighted today at the 18th Congress of the ... . "The data presented today demonstrate lasmiditan,s ...
(Date:9/7/2017)... Texas , Sept. 7, 2017 ... science focused on fulfilling the promise of precision ... further validate the benefits of its molecular profiling ... study utilized comprehensive genomic profiling plus (CGP+) with ... individual patient,s tumor on a molecular level, leading ...
(Date:9/7/2017)... , Sept. 7, 2017   BioLife Solutions , ... and marketer of proprietary clinical grade cell and tissue ... announces that Mike Rice , President and CEO, will ... Rodman & Renshaw 19 th Annual ... Eastern time (12:25 p.m. Pacific time). The conference is being ...
Breaking Medicine Technology:
Cached News: